Starting treatment gets all the attention. Stopping it — when you've met your goals, when the cost-benefit no longer works, or when life circumstances change — gets almost none. Each therapy in the men's health stack has different discontinuation considerations, and some require more planning than others.
Discontinuing TRT
Stopping testosterone replacement is the most complex discontinuation in the stack because it triggers HPG axis recovery — a process that varies in duration and completeness.
What happens: Exogenous testosterone has suppressed your LH and FSH production. When you stop, the pituitary needs time to restart signaling. During this recovery period (typically 4–12 weeks, sometimes longer), testosterone levels drop below baseline before gradually recovering. Symptoms during recovery can include fatigue, low mood, decreased libido, and muscle loss.
The options:
- Cold stop: Simply stop injecting. The simplest approach but produces the most symptomatic withdrawal period as testosterone levels drop before recovery begins.
- Taper: Gradually reduce dose over 4–6 weeks before stopping. Reduces the severity of the hormonal trough.
- Bridge with enclomiphene or HCG: Transition from TRT to enclomiphene or HCG monotherapy to support endogenous recovery while maintaining some testosterone support. This is the approach most experienced clinicians recommend for planned discontinuation.
Timeline: Most men recover endogenous testosterone production within 3–6 months. Some require up to 12 months. A small percentage (particularly after very long-term use) may not fully recover to pre-TRT levels.
Discontinuing GLP-1 Medications
What happens: GLP-1 receptor agonists don't create physical dependence, but stopping them reverses the appetite suppression, gastric emptying changes, and metabolic effects they provided. Weight regain is the primary concern — published data shows that approximately two-thirds of weight lost on semaglutide is regained within one year of discontinuation if no other intervention replaces it.
The approach:
- Don't stop abruptly at peak dose: Taper down one dose level at a time (e.g., from 2.4mg to 1.7mg to 1.0mg semaglutide) over 2–3 months.
- Establish maintenance habits before stopping: Nutritional patterns, exercise routines, and behavioral strategies need to be in place before the pharmaceutical appetite suppression is removed.
- Consider maintenance dosing: Some clinicians recommend a low maintenance dose rather than complete discontinuation — ongoing research is evaluating whether lower-dose long-term GLP-1 therapy prevents regain.
Discontinuing ED Medications
What happens: PDE5 inhibitors create no physical dependence. Stopping produces no withdrawal symptoms. Erectile function returns to whatever your underlying status is without pharmaceutical support.
The consideration: If your ED was a symptom of a treatable underlying condition (obesity, hormonal deficiency, vascular disease) that you've addressed through other therapies, you may not need ED medication anymore. Test by skipping the medication and seeing if function is adequate. If your ED has an irreversible organic component, you'll likely need to continue or resume.
Discontinuing Finasteride
What happens: Stopping finasteride allows DHT levels to return to baseline within 1–2 weeks. Hair loss typically resumes within 3–6 months at the rate it would have progressed without treatment. Any hair gained or maintained by finasteride is at risk of being lost. This is a common source of regret — men stop finasteride feeling fine, then watch their hair thin over the following months.
Discontinuation Summary
- TRT: Plan ahead. Bridge with enclomiphene/HCG if possible. Expect 3–6 month recovery. Monitor with labs.
- GLP-1: Taper gradually. Establish habits first. Consider maintenance dosing. Expect appetite return.
- ED meds: No taper needed. Test underlying function periodically.
- Finasteride: No taper needed. Understand hair loss will resume. Decision is reversible — can restart.
The Bottom Line
Plan the Exit as Carefully as the Entry
Every medication in your stack has a discontinuation profile. TRT requires the most planning; ED meds require the least. The common mistake is treating discontinuation as simply "stop taking it" when some therapies benefit from tapering, bridging, or preparatory habit changes. Discuss your exit plan with your prescriber before you need it.